As of January 23, 2025, Femasys (FEMY) has a market cap of $26.104 million USD. According to our data, Femasys is ranked No.8495 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $26.10 M |
3.64%
|
Dec 31, 2024 | $25.19 M |
12.82%
|
Dec 29, 2023 | $22.33 M |
8.33%
|
Dec 30, 2022 | $20.61 M |
-76.92%
|
Dec 31, 2021 | $89.30 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Hologic
HOLX
|
$16.07 B |
-0.000 M
|
USA
|
Cooper Companies
COO
|
$19.00 B |
-0.001 M
|
USA
|
FutureFuel
FF
|
$0.24 B |
0.000 M
|
USA
|
Progyny
PGNY
|
$1.80 B |
-0.000 M
|
USA
|
Natera
NTRA
|
$22.70 B |
-0.001 M
|
USA
|
Myriad Genetics
MYGN
|
$1.12 B |
-0.000 M
|
USA
|
Illumina
ILMN
|
$22.26 B |
0.000 M
|
USA
|
Thermo Fisher Scientific
TMO
|
$219.78 B |
-0.008 M
|
USA
|
Bio-Rad Laboratories
BIO
|
$10.07 B |
1.804 B
|
USA
|
Qiagen
QGEN
|
$10.50 B |
0.000 M
|
Netherlands
|
Guardant Health
GH
|
$5.83 B |
0.000 M
|
USA
|
Market Cap | = | FEMY Stock Price | * | FEMY Shares Outstanding |
= | $1.14 | * | 22.90 M | |
= | $26.10 M |